Longboard Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Revenue	171,742	163,997	136,733	134,914	130,868	136,971	Upgrade
Revenue Growth (YoY)	27.63%	19.94%	1.35%	3.09%	-4.46%	12.84%	Upgrade
Cost of Revenue	70,461	71,354	75,743	70,825	64,931	62,040	Upgrade
Gross Profit	101,281	92,643	60,990	64,089	65,937	74,931	Upgrade
Selling, General & Admin	55,945	57,869	58,113	57,181	54,861	53,845	Upgrade
Research & Development	-	-	770	806	64	167	Upgrade
Other Operating Expenses	-1,319	2	-319	-794	-3,460	-3,016	Upgrade
Operating Expenses	55,955	59,200	60,329	59,163	53,760	55,054	Upgrade
Operating Income	45,326	33,443	661	4,926	12,177	19,877	Upgrade
Interest Expense	-937	-274	-162	-167	-94	-77	Upgrade
Interest & Investment Income	-	1,720	1,953	3,180	3,739	2,933	Upgrade
Earnings From Equity Investments	4,192	2,309	-2,992	1,770	14,226	3,275	Upgrade
Currency Exchange Gain (Loss)	-126	-126	1,429	804	1,448	794	Upgrade
Other Non Operating Income (Expenses)	-	1	-	-16	-10	-60	Upgrade
EBT Excluding Unusual Items	48,455	37,073	889	10,497	31,486	26,742	Upgrade
Gain (Loss) on Sale of Investments	-785	-785	-88	3,602	2,207	9,788	Upgrade
Gain (Loss) on Sale of Assets	-81	-81	-167	-141	-30	-125	Upgrade
Asset Writedown	-4,389	-4,389	-28,764	-364	-4,244	-5,146	Upgrade
Pretax Income	43,200	31,818	-28,130	13,594	29,419	31,259	Upgrade
Income Tax Expense	12,006	8,852	2,057	4,934	-1,232	4,905	Upgrade
Earnings From Continuing Operations	31,194	22,966	-30,187	8,660	30,651	26,354	Upgrade
Minority Interest in Earnings	1,150	1,227	1,505	197	-119	-724	Upgrade
Net Income	32,344	24,193	-28,682	8,857	30,532	25,630	Upgrade
Net Income to Common	32,344	24,193	-28,682	8,857	30,532	25,630	Upgrade
Net Income Growth	-	-	-	-70.99%	19.13%	-	Upgrade
Shares Outstanding (Basic)	111	111	111	115	119	123	Upgrade
Shares Outstanding (Diluted)	112	112	111	115	119	124	Upgrade
Shares Change (YoY)	0.23%	0.16%	-3.57%	-3.10%	-3.64%	-11.34%	Upgrade
EPS (Basic)	290.38	217.24	-257.59	76.77	256.45	207.54	Upgrade
EPS (Diluted)	289.80	216.92	-257.60	76.70	256.20	207.24	Upgrade
EPS Growth	-	-	-	-70.06%	23.63%	-	Upgrade
Free Cash Flow	33,957	34,747	-14,384	10,184	17,875	26,530	Upgrade
Free Cash Flow Per Share	304.26	311.56	-129.18	88.19	149.99	214.52	Upgrade
Dividend Per Share	33.000	33.000	20.000	20.000	39.000	32.000	Upgrade
Dividend Growth	65.00%	65.00%	-	-48.72%	21.88%	60.00%	Upgrade
Gross Margin	58.97%	56.49%	44.60%	47.50%	50.38%	54.71%	Upgrade
Operating Margin	26.39%	20.39%	0.48%	3.65%	9.30%	14.51%	Upgrade
Profit Margin	18.83%	14.75%	-20.98%	6.57%	23.33%	18.71%	Upgrade
Free Cash Flow Margin	19.77%	21.19%	-10.52%	7.55%	13.66%	19.37%	Upgrade
EBITDA	51,022	38,594	7,201	10,371	17,770	26,580	Upgrade
EBITDA Margin	29.71%	23.53%	5.27%	7.69%	13.58%	19.41%	Upgrade
D&A For EBITDA	5,696	5,151	6,540	5,445	5,593	6,703	Upgrade
EBIT	45,326	33,443	661	4,926	12,177	19,877	Upgrade
EBIT Margin	26.39%	20.39%	0.48%	3.65%	9.30%	14.51%	Upgrade
Effective Tax Rate	27.79%	27.82%	-	36.30%	-	15.69%	Upgrade
Advertising Expenses	-	13,284	15,833	15,793	14,404	11,309	Upgrade

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.